AVITA Medical (RCEL) Accounts Payables (2018 - 2025)
AVITA Medical filings provide 8 years of Accounts Payables readings, the most recent being $9.0 million for Q4 2025.
- On a quarterly basis, Accounts Payables rose 42.34% to $9.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $9.0 million, a 42.34% increase, with the full-year FY2025 number at $9.0 million, up 42.34% from a year prior.
- Accounts Payables hit $9.0 million in Q4 2025 for AVITA Medical, up from $8.1 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $9.0 million in Q4 2025 to a low of $2.4 million in Q1 2022.
- Median Accounts Payables over the past 5 years was $3.8 million (2023), compared with a mean of $4.5 million.
- Biggest five-year swings in Accounts Payables: crashed 34.11% in 2022 and later surged 93.81% in 2025.
- AVITA Medical's Accounts Payables stood at $2.7 million in 2021, then rose by 10.86% to $3.0 million in 2022, then rose by 26.35% to $3.8 million in 2023, then skyrocketed by 65.94% to $6.3 million in 2024, then surged by 42.34% to $9.0 million in 2025.
- The last three reported values for Accounts Payables were $9.0 million (Q4 2025), $8.1 million (Q3 2025), and $7.3 million (Q2 2025) per Business Quant data.